Cryosite Ltd

CTE

Company Profile

  • Business description

    Cryosite Ltd provides an integrated clinical trial logistics service, biological storage and sample management service, including the storage of cord blood stem cells for private use. It supports a diverse portfolio of materials, including Good Manufacturing Practice (GMP) clinical trial products, Australian Register of Therapeutic Goods (ARTG) approved medicines, biologics, Research and Development materials, and medical devices, among others. The group's operating segments are: Ambient, cold, and frozen; Ultra-frozen and cryogenic; and Cord blood. The majority of its revenue is generated from the Ambient, cold, and frozen segment, which provides storage and distribution of small-molecule drugs and related products requiring ambient, refrigerated, or frozen conditions.

  • Contact

    13a Ferndell Street
    South Granville
    SydneyNSW2142
    AUS

    T: +61 288652000

    https://www.cryosite.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Diagnostics & Research

    Fiscal Year End

    30 June 2026

    Employees

    25

Stocks News & Analysis

stocks

The 5 best US dividend aristocrats to watch in 2026

How to avoid the dividend aristocrat trap.
stocks

Chart of the Week: Is CSL finally turning the ship around?

The beaten down healthcare giant remains cheap on turnaround potential.
stocks

ASX top pick remains cheap with narrowing brand focus

Shares remain cheap for ASX winemaker as the company narrows focus on high margin brands.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries8,843.9078.400.89%
CAC 408,161.8341.60-0.51%
DAX 4024,195.31237.75-0.97%
Dow JONES (US)49,918.78953.33-1.87%
FTSE 10010,254.8127.480.27%
HKSE24,141.13266.83-1.09%
NASDAQ25,169.50509.32-1.98%
Nikkei 22564,056.44122.83-0.19%
NZX 50 Index13,202.1651.49-0.39%
S&P 5007,266.99119.66-1.62%
S&P/ASX 2008,642.5079.000.92%
SSE Composite Index3,978.5314.69-0.37%

Market Movers